William M. Wardell

935 total citations
46 papers, 684 citations indexed

About

William M. Wardell is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, William M. Wardell has authored 46 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Economics and Econometrics, 16 papers in Pediatrics, Perinatology and Child Health and 10 papers in Pharmacology. Recurrent topics in William M. Wardell's work include Pharmaceutical Economics and Policy (19 papers), Pharmaceutical studies and practices (13 papers) and Pharmaceutical industry and healthcare (8 papers). William M. Wardell is often cited by papers focused on Pharmaceutical Economics and Policy (19 papers), Pharmaceutical studies and practices (13 papers) and Pharmaceutical industry and healthcare (8 papers). William M. Wardell collaborates with scholars based in United States, Australia and Japan. William M. Wardell's co-authors include Louis Lasagna, Olav M. Bakke, S. N. Anavekar, Henry T. Davis, Mohammed Hassar, J. F. Calimlim, Kensuke Nakamura, C. Ogura, Kyoko Nakazawa and A J Gillies and has published in prestigious journals such as JAMA, Annals of the New York Academy of Sciences and Anesthesiology.

In The Last Decade

William M. Wardell

42 papers receiving 560 citations

Peers

William M. Wardell
Graham Lewis United Kingdom
Shanthi Pal Switzerland
J K Aronson United Kingdom
G R Venning United Kingdom
Marcella A. Evans United States
Simon Sanderson United Kingdom
Zaina P. Qureshi United States
Graham Lewis United Kingdom
William M. Wardell
Citations per year, relative to William M. Wardell William M. Wardell (= 1×) peers Graham Lewis

Countries citing papers authored by William M. Wardell

Since Specialization
Citations

This map shows the geographic impact of William M. Wardell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William M. Wardell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William M. Wardell more than expected).

Fields of papers citing papers by William M. Wardell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William M. Wardell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William M. Wardell. The network helps show where William M. Wardell may publish in the future.

Co-authorship network of co-authors of William M. Wardell

This figure shows the co-authorship network connecting the top 25 collaborators of William M. Wardell. A scholar is included among the top collaborators of William M. Wardell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William M. Wardell. William M. Wardell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McLeod, Katherine, Mo Korchinski, Pamela Young, et al.. (2021). Supporting people leaving prisons during COVID-19: perspectives from peer health mentors. International Journal of Prisoner Health. 17(3). 206–216. 12 indexed citations
2.
Brater, D. Craig, Beth Benedict, Timothy R. Franson, et al.. (1991). Panel I. Drug utilization review: Criteria*. Clinical Pharmacology & Therapeutics. 50(5 Pt 2). 626–628. 1 indexed citations
3.
Bakke, Olav M., William M. Wardell, & Louis Lasagna. (1984). Drug discontinuations in the United Kingdom and the United States, 1964 to 1983: Issues of safety. Clinical Pharmacology & Therapeutics. 35(5). 559–567. 69 indexed citations
4.
Wardell, William M., et al.. (1984). The development of self-originated new drugs by Swiss pharmaceutical firms, 1960–1980. Regulatory Toxicology and Pharmacology. 4(2). 157–173. 8 indexed citations
5.
Calimlim, J. F., William M. Wardell, & Christopher Cox. (1982). Analgesic efficacy of orally administered zomepirac sodium. Clinical Pharmacology & Therapeutics. 31(2). 1 indexed citations
6.
Wardell, William M., et al.. (1981). Research activity on systemic contraceptive drugs by the U.S. pharmaceutical industry, 1963–1976. Contraception. 23(4). 345–365. 1 indexed citations
7.
Wardell, William M., et al.. (1979). Postmarketing Surveillance of New Drugs: I. Review of Objectives and Methodology. The Journal of Clinical Pharmacology. 19(2-3). 85–94. 29 indexed citations
8.
Wardell, William M., et al.. (1978). NATIONAL RATES AND PATTERNS OF CONSUMPTION OF ANTIHYPERTENSIVE DRUGS IN RELATION TO THEIR AVAILABILITY IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA AND NEW ZEALAND*. Annals of the New York Academy of Sciences. 304(1). 320–330. 4 indexed citations
9.
Wardell, William M.. (1978). History and application of drug safety and efficacy requirements in the United States. Inflammation Research. 8(4). 420–421. 4 indexed citations
10.
Anavekar, S. N., et al.. (1978). Parotid and whole saliva in the prediction of serum total and free phenytoin concentrations. Clinical Pharmacology & Therapeutics. 24(6). 629–637. 29 indexed citations
11.
Wardell, William M., Mohammed Hassar, & S. N. Anavekar. (1978). The rate of development of new drugs in the United States, 1963 through 1975. Clinical Pharmacology & Therapeutics. 24(2). 133–145. 25 indexed citations
12.
Wardell, William M.. (1975). Consultative Services in Clinical Pharmacology. The Journal of Clinical Pharmacology. 15(11-12). 721–724. 2 indexed citations
13.
Blackwell, Barry, Paul D. Stolley, Ralph Buncher, et al.. (1975). Panel 4: Phase IV investigations. Clinical Pharmacology & Therapeutics. 18(5part2). 653–656. 3 indexed citations
14.
Wardell, William M.. (1974). Clinical Pharmacology at University Medical Centers. II. Requirements. The Journal of Clinical Pharmacology. 14(8-9). 408–414.
15.
Wardell, William M.. (1974). Clinical Pharmacology at University Medical Centers. I. Functions and Organization. The Journal of Clinical Pharmacology. 14(7). 309–324. 7 indexed citations
16.
Wardell, William M.. (1974). Therapeutic implications of the drug lag. Clinical Pharmacology & Therapeutics. 15(1). 73–96. 40 indexed citations
17.
Wardell, William M.. (1974). Control of drug utilization in the context of a national health service: The New Zealand system. Clinical Pharmacology & Therapeutics. 16(3part2). 585–594. 2 indexed citations
18.
Calimlim, J. F., et al.. (1974). Effect of naloxone on the analgesic activity of methadone in a 1:10 oral combination; Time and cost of flirting with the null hypothesis in tests of equivalence. Clinical Pharmacology & Therapeutics. 15(6). 556–564. 4 indexed citations
19.
Wardell, William M.. (1973). British usage and American awareness of some new therapeutic drugs. Clinical Pharmacology & Therapeutics. 14(6). 1022–1034. 18 indexed citations
20.
Wardell, William M.. (1973). Introduction of new therapeutic drugs in the United States and Great Britain: An international comparison. Clinical Pharmacology & Therapeutics. 14(5). 773–790. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026